Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 11, Issue 14, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-07-05
DOI
10.1161/jaha.122.025723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2021) Kirsten L. Johansen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
- (2021) Jan Steffel et al. EUROPACE
- Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
- (2021) Silvia Fernandez et al. Journal of Personalized Medicine
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
- (2021) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
- (2020) Sarah Hanigan et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Translating claims-based CHA2 DS2 -VaSc and HAS-BLED to ICD-10-CM: Impacts of mapping strategies
- (2020) Michael Webster-Clark et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease
- (2020) Clarisse Roux-Marson et al. BMC Geriatrics
- Drug–Drug Interactions with Direct Oral Anticoagulants
- (2020) Kathrin I. Foerster et al. CLINICAL PHARMACOKINETICS
- Select Drug-Drug Interactions With Direct Oral Anticoagulants
- (2020) Barbara S. Wiggins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug-drug interactions affecting drug levels of direct oral anticoagulants in the real world: A systematic review
- (2020) Allen Li et al. THROMBOSIS RESEARCH
- Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
- (2020) Phuong Pham et al. JAMA Network Open
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports
- (2020) Silvia Fernandez et al. Pharmacology Research & Perspectives
- Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
- (2020) Michele Magnocavallo et al. Journal of Clinical Medicine
- Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
- (2019) Minsoo Kim et al. Pharmaceutics
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
- (2019) Shankar Kumar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
- (2018) Jung-Im Shin et al. Clinical Journal of the American Society of Nephrology
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Drug Interactions With Non–Vitamin K Oral Anticoagulants
- (2018) Anne-Laure Sennesael et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drug Interactions With Non–Vitamin K Oral Anticoagulants
- (2018) Sara R. Vazquez et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drug Interactions With Non–Vitamin K Oral Anticoagulants
- (2018) Yan Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem
- (2018) Jenna W. Bartlett et al. ANNALS OF PHARMACOTHERAPY
- Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
- (2017) Shang-Hung Chang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Missing data and multiple imputation in clinical epidemiological research
- (2017) Alma Pedersen et al. Clinical Epidemiology
- On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With WarfarinClinical Perspective
- (2016) Christopher B. Fordyce et al. CIRCULATION
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
- (2015) M. Jun et al. BMJ-British Medical Journal
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
- (2015) M. Jun et al. BMJ-British Medical Journal
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Subclinical Atrial Fibrillation and the Risk of Stroke
- (2012) Jeff S. Healey et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now